Citations (128)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Carmen McLeod, Brigitte Nerlich & Rusi Jaspal. (2019) Fecal microbiota transplants: emerging social representations in the English-language print media. New Genetics and Society 38:3, pages 331-351.
Read now
Read now
Kathryn A Bowman, Elizabeth K Broussard & Christina M Surawicz. (2015) Fecal microbiota transplantation: current clinical efficacy and future prospects. Clinical and Experimental Gastroenterology 8, pages 285-291.
Read now
Read now
Stephen M Vindigni, Elizabeth K Broussard & Christina M Surawicz. (2013) Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Review of Gastroenterology & Hepatology 7:7, pages 615-628.
Read now
Read now
Aijaz Ahmed Sofi, Ann Lynn Silverman, Sadik Khuder, Kjetil Garborg, Julie M. A Westerink & Ali Nawras. (2013) Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review. Scandinavian Journal of Gastroenterology 48:3, pages 266-273.
Read now
Read now
Christina Jorup-Rönström, Anders Håkanson, Staffan Sandell, Ove Edvinsson, Tore Midtvedt, Anna-Karin Persson & Elisabeth Norin. (2012) Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients. Scandinavian Journal of Gastroenterology 47:5, pages 548-552.
Read now
Read now
Emma L. Best, Jane Freeman & Mark H. Wilcox. (2012) Models for the study of Clostridium difficile infection. Gut Microbes 3:2, pages 145-167.
Read now
Read now
Kjetil Garborg, Bjørn Waagsbø, Asbjørn Stallemo, Jon Matre & Anders Sundøy. (2010) Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scandinavian Journal of Infectious Diseases 42:11-12, pages 857-861.
Read now
Read now
Mette Helvik Morken, Jørgen Valeur, Elisabeth Norin, Tore Midtvedt, Gunnar Nysæter & Arnold Berstad. (2009) Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome. Scandinavian Journal of Gastroenterology 44:11, pages 1296-1303.
Read now
Read now
A.C. Senok & V.O. Rotimi. (2008) The Management of Clostridium difficile Infection: Antibiotics, Probiotics and Other Strategies. Journal of Chemotherapy 20:1, pages 5-13.
Read now
Read now
Crenguta Stepan & Christina M Surawicz. (2007) Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea. Expert Review of Gastroenterology & Hepatology 1:2, pages 295-305.
Read now
Read now
S. Pathmakanthan, S. Meance, C. A. Edwards. (2000) Probiotics: A Review of Human Studies to Date and Methodological Approaches. Microbial Ecology in Health and Disease 12:2, pages 10-30.
Read now
Read now
A. Gustafsson, A. Berstad, S. Lund-Tønnesen, T. Midtvedt, E. Norin. (1999) The Effect of Faecal Enema on Five Microflora-Associated Characteristics in Patients with Antibiotic-Associated Diarrhoea. Scandinavian Journal of Gastroenterology 34:6, pages 580-586.
Read now
Read now
A. GUSTAFSSON, S. LUND-TØNNESEN, A. BERSTAD, T. MIDTVEDT, E. NORIN. (1998) Faecal Short-Chain Fatty Acids in Patients with Antibiotic-Associated Diarrhoea, before and after Faecal Enema Treatment. Scandinavian Journal of Gastroenterology 33:7, pages 721-727.
Read now
Read now
B. W. Wolf, K. A. Garleb, D. G. Ataya & I. A. Casas. (1995) Safety and Tolerance of Lactobacillus reuteri in Healthy Adult Male Subjects. Microbial Ecology in Health and Disease 8:2, pages 41-50.
Read now
Read now
S. Peter Borriello. (1990) The Influence of the Normal Flora on Clostridium difficile Colonisation of the Gut. Annals of Medicine 22:1, pages 61-67.
Read now
Read now
S. P. Borriello, Fiona E. Barclay & A. R. Welch. (1988) Evaluation of the predictive capability of an in-vitro model of colonisation resistance to Clostridium difficile infection. Microbial Ecology in Health and Disease 1:1, pages 61-64.
Read now
Read now
Articles from other publishers (112)
Craig R. MacNair, Caressa N. Tsai, Steven T. Rutherford & Man-Wah Tan. (2023) Returning to Nature for the Next Generation of Antimicrobial Therapeutics. Antibiotics 12:8, pages 1267.
Crossref
Crossref
Maurício Roberto Motta Pinto da Luz & Ricardo Francisco Waizbort. (2020) Transplantes de microbiota fecal para tratamento da colite pseudomembranosa (1958-2013): prioridade de descoberta e estilos de pensamento na literatura acadêmica. História, Ciências, Saúde-Manguinhos 27:3, pages 859-878.
Crossref
Crossref
Cheng-Yue Jin, Ying Hu & Bo Jin. (2020) Faecal microbiota transplantation: Application in treatment of some digestive diseases and safety concerns. World Chinese Journal of Digestology 28:4, pages 135-143.
Crossref
Crossref
T.V. Riley, D. Lyras & G.R. Douce. (2019) Status of vaccine research and development for Clostridium difficile. Vaccine 37:50, pages 7300-7306.
Crossref
Crossref
Bryan Tungland. 2018. Human Microbiota in Health and Disease. Human Microbiota in Health and Disease
381
419
.
Bryan Tungland. 2018. Human Microbiota in Health and Disease. Human Microbiota in Health and Disease
197
288
.
Juan Jovel, Levinus A. Dieleman, Dina Kao, Andrew L. Mason & Eytan Wine. 2018. Metagenomics. Metagenomics
197
213
.
M. Baxter & A. Colville. (2016) Adverse events in faecal microbiota transplant: a review of the literature. Journal of Hospital Infection 92:2, pages 117-127.
Crossref
Crossref
Chris Dowle. (2016)
Faecal microbiota transplantation: a review of FMT as an alternative treatment for
Clostridium difficile
infection
. Bioscience Horizons 9, pages hzw007.
Crossref
Crossref
Meirav Pevsner-Fischer, Chagai Rot, Timur Tuganbaev & Eran Elinav. 2016. Immune Rebalancing. Immune Rebalancing
191
227
.
Yasmeen Vincent, Arif Manji, Kathleen Gregory-Miller & Christine Lee. (2015) A Review of Management of Clostridium difficile Infection: Primary and Recurrence. Antibiotics 4:4, pages 411-423.
Crossref
Crossref
Noortje G Rossen. (2015) Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World Journal of Gastroenterology 21:17, pages 5359.
Crossref
Crossref
Chetana Vaishnavi. (2014) Fecal microbiota transplantation for management of Clostridium difficile infection. Indian Journal of Gastroenterology 33:4, pages 301-307.
Crossref
Crossref
S. Sha, J. Liang, M. Chen, B. Xu, C. Liang, N. Wei & K. Wu. (2014) Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Alimentary Pharmacology & Therapeutics 39:10, pages 1003-1032.
Crossref
Crossref
J. C. O’Horo, K. Jindai, B. Kunzer & N. Safdar. (2013) Treatment of recurrent Clostridium difficile infection: a systematic review. Infection 42:1, pages 43-59.
Crossref
Crossref
Thomas J BorodyDebra Peattie & Amit Kapur. (2014)
Could fecal microbiota transplantation cure all
Clostridium difficile
infections?
. Future Microbiology 9:1, pages 1-3.
Crossref
Crossref
Robert Orenstein, Cheryl L. Griesbach & John K. DiBaise. (2013) Moving Fecal Microbiota Transplantation Into the Mainstream. Nutrition in Clinical Practice 28:5, pages 589-598.
Crossref
Crossref
Kristin E. Burke & John T. Lamont. (2013)
Fecal Transplantation for Recurrent
Clostridium difficile
Infection in Older Adults: A Review
. Journal of the American Geriatrics Society 61:8, pages 1394-1398.
Crossref
Crossref
Ramesh C. Chandan & Nagendra P. Shah. 2013. Manufacturing Yogurt and Fermented Milks. Manufacturing Yogurt and Fermented Milks
411
431
.
Thomas Julius Borody & Jordana Campbell. (2012) Fecal Microbiota Transplantation. Gastroenterology Clinics of North America 41:4, pages 781-803.
Crossref
Crossref
Faith Rohlke & Neil Stollman. (2012)
Fecal microbiota transplantation in relapsing
Clostridium difficile
infection
. Therapeutic Advances in Gastroenterology 5:6, pages 403-420.
Crossref
Crossref
Frank Myers. (2012) Making the case for fecal bacteriotherapy. Nursing Critical Care 7:4, pages 42-46.
Crossref
Crossref
Frank Myers. (2012) Un tratamiento no convencional: la bacterioterapia fecal. Nursing (Ed. española) 30:3, pages 26-29.
Crossref
Crossref
Colleen R. Kelly, Lauren de Leon & Niren Jasutkar. (2012) Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients. Journal of Clinical Gastroenterology 46:2, pages 145-149.
Crossref
Crossref
Thomas J. Borody & Alexander Khoruts. (2011) Fecal microbiota transplantation and emerging applications. Nature Reviews Gastroenterology & Hepatology 9:2, pages 88-96.
Crossref
Crossref
Frank Myers. (2011) Beyond mainstream. Nursing 41:12, pages 50-53.
Crossref
Crossref
Ethan Gough, Henna Shaikh & Amee R. Manges. (2011) Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection. Clinical Infectious Diseases 53:10, pages 994-1002.
Crossref
Crossref
Claire M.F. van Nispen tot Pannerden, Annelies Verbon & Ernst J. Kuipers. (2011) Recurrent Clostridium difficile Infection. Drugs 71:7, pages 853-868.
Crossref
Crossref
Jonathan E. Teitelbaum. 2011. Pediatric Gastrointestinal and Liver Disease. Pediatric Gastrointestinal and Liver Disease
28
38.e5
.
Lynne V McFarland & Christina M Surawicz. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
335
354
.
Martin J. Grehan, Thomas Julius Borody, Sharyn M. Leis, Jordana Campbell, Hazel Mitchell & Antony Wettstein. (2010) Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora. Journal of Clinical Gastroenterology 44:8, pages 551-561.
Crossref
Crossref
Martin H. Floch. (2010) Fecal Bacteriotherapy, Fecal Transplant, and the Microbiome. Journal of Clinical Gastroenterology 44:8, pages 529-530.
Crossref
Crossref
C.-M. Surawicz. (2010) The Microbiota and infectious diarrhea. Gastroentérologie Clinique et Biologique 34, pages S29-S36.
Crossref
Crossref
C.-M. Surawicz. (2010) Le microbiote dans les diarrhées infectieuses. Gastroentérologie Clinique et Biologique 34:4, pages 31-40.
Crossref
Crossref
Alexander Khoruts, Johan Dicksved, Janet K. Jansson & Michael J. Sadowsky. (2010) Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea. Journal of Clinical Gastroenterology 44:5, pages 354-360.
Crossref
Crossref
S. Peter Borriello & Klaus Aktories. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
NATHAN M. THIELMAN & KENNETH H. WILSON. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1375
1387
.
Johan S. Bakken. (2009) Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15:6, pages 285-289.
Crossref
Crossref
A.A. MacConnachie, R. Fox, D.R. Kennedy & R.A. Seaton. (2009) Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM 102:11, pages 781-784.
Crossref
Crossref
T Monaghan, T Boswell & Y R Mahida. (2009)
Recent advances in
Clostridium difficile
-associated disease
. Postgraduate Medical Journal 85:1001, pages 152-162.
Crossref
Crossref
Perry Hookman & Jamie S Barkin. (2009) Clostridium diffcile associated infection, diarrhea andcolitis. World Journal of Gastroenterology 15:13, pages 1554.
Crossref
Crossref
John G. Bartlett. (2008) New antimicrobial agents for patients with Clostridium difficile infections. Current Infectious Disease Reports 11:1, pages 21-28.
Crossref
Crossref
Mazen Issa, Ashwin N. Ananthakrishnan & David G. Binion. (2008) Clostridium difficile and inflammatory bowel disease. Inflammatory Bowel Diseases 14:10, pages 1432-1442.
Crossref
Crossref
Daniel M. Musher & Saima Aslam. 2008. Emerging Infections 8. Emerging Infections 8
313
335
.
Matthew T. Oughton & Mark A. Miller. (2008) Clinical and Epidemiological Aspects of Clostridium difficile. Clinical Microbiology Newsletter 30:12, pages 87-95.
Crossref
Crossref
Jennifer Halsey. (2008)
Current and future treatment modalities for
Clostridium difficile
-associated disease
. American Journal of Health-System Pharmacy 65:8, pages 705-715.
Crossref
Crossref
Daniel M. Musher & Saima Aslam. (2008) Treatment of Clostridium Difficile Colitis in the Critical Care Setting. Critical Care Clinics 24:2, pages 279-291.
Crossref
Crossref
John G. Bartlett. (2008)
Historical Perspectives on Studies of
Clostridium difficile
and
C. difficile
Infection
. Clinical Infectious Diseases 46:s1, pages S4-S11.
Crossref
Crossref
Dale N. Gerding, Carlene A. Muto & Robert C. Owens, Jr.. (2008)
Treatment of
Clostridium difficile
Infection
. Clinical Infectious Diseases 46:s1, pages S32-S42.
Crossref
Crossref
Itzhak Brook. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
966
969
.
B. Razavi, A. Apisarnthanarak & L. M. Mundy. (2007) Clostridium difficile: Emergence of Hypervirulence and Fluoroquinolone Resistance. Infection 35:5, pages 300-307.
Crossref
Crossref
Itzhak Brook. 2007. Anaerobic Infections. Anaerobic Infections
325
330
.
Mark A. Miller. (2007) Clinical Management of Clostridium difficile-Associated Disease. Clinical Infectious Diseases 45:Supplement_2, pages S122-S128.
Crossref
Crossref
Dorothy Surowiec, Arpi G Kuyumjian, Michael A Wynd & Cristina E Cicogna. (2016) Past, Present, and Future Therapies for Clostridium difficile–Associated Disease. Annals of Pharmacotherapy 40:12, pages 2155-2163.
Crossref
Crossref
Emilio Bouza, Almudena Burillo & Patricia Muñoz. (2006) Antimicrobial Therapy of Clostridium difficile-Associated Diarrhea. Medical Clinics of North America 90:6, pages 1141-1163.
Crossref
Crossref
. (2006) Commentary. Annals of Emergency Medicine 48:1, pages 57-59.
Crossref
Crossref
Elizabeth S. Huebner & Christina M. Surawicz. (2006) Probiotics in the Prevention and Treatment of Gastrointestinal Infections. Gastroenterology Clinics of North America 35:2, pages 355-365.
Crossref
Crossref
Stuart McPherson, Colin J. Rees, Richard Ellis, Shelly Soo & Simon J. Panter. (2006) Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea. Diseases of the Colon & Rectum 49:5, pages 640-645.
Crossref
Crossref
Ramesh C. Chandan & Nagendra P. Shah. 2006. Manufacturing Yogurt and Fermented Milks. Manufacturing Yogurt and Fermented Milks
311
326
.
I Tonna & P D Welsby. (2005)
Pathogenesis and treatment of
Clostridium difficile
infection
. Postgraduate Medical Journal 81:956, pages 367-369.
Crossref
Crossref
ITZHAK BROOK. (2005) Pseudomembranous colitis in children. Journal of Gastroenterology and Hepatology 20:2, pages 182-186.
Crossref
Crossref
Lynne V McFarland. (2005) Alternative treatments for Clostridium difficile disease: what really works?. Journal of Medical Microbiology 54:2, pages 101-111.
Crossref
Crossref
Bryan Wolf, JoMay Chow & Keith Garleb. 2004. Polysaccharides. Polysaccharides.
Lynne V McFarland & Christina M Surawicz. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
285
301
.
Christina M Surawicz. (2004) Treatment of recurrent Clostridium difficile-associated disease. Nature Clinical Practice Gastroenterology & Hepatology 1:1, pages 32-38.
Crossref
Crossref
ITZHAK BROOK. (2004) Pseudomembranous colitis in children. Journal of Gastroenterology and Hepatology 0:0, pages 060606032707121.
Crossref
Crossref
John R. Stroehlein. (2004) Treatment of clostridium difficile infection. Current Treatment Options in Gastroenterology 7:3, pages 235-239.
Crossref
Crossref
Paul Naaber & Marika Mikelsaar. 2004.
231
260
.
Christina M Surawicz. (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Practice & Research Clinical Gastroenterology 17:5, pages 775-783.
Crossref
Crossref
Mark H Wilcox. (2003) Clostridium difficile infection and pseudomembranous colitis. Best Practice & Research Clinical Gastroenterology 17:3, pages 475-493.
Crossref
Crossref
Johannes Aas, Charles E. Gessert & Johan S. Bakken. (2003)
Recurrent
Clostridium difficile
Colitis: Case Series Involving 18 Patients Treated with Donor Stool Administered via a Nasogastric Tube
. Clinical Infectious Diseases 36:5, pages 580-585.
Crossref
Crossref
John G. Bartlett. (2002) Clostridium difficile-associated enteric disease. Current Infectious Disease Reports 4:6, pages 477-483.
Crossref
Crossref
Stephen DH Malnick & Oren Zimhony. (2016)
Treatment of
Clostridium Difficile
-Associated Diarrhea
. Annals of Pharmacotherapy 36:11, pages 1767-1775.
Crossref
Crossref
Jonathan E. TeitelbaumW. Allan Walker. (2002)
N
UTRITIONAL
I
MPACT OF
P
RE- AND
P
ROBIOTICS AS
P
ROTECTIVE
G
ASTROINTESTINAL
O
RGANISMS
. Annual Review of Nutrition 22:1, pages 107-138.
Crossref
Crossref
Lynne V McFarland, Gary W Elmer & Christina M Surawicz. (2002) Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease. American Journal of Gastroenterology 97:7, pages 1769-1775.
Crossref
Crossref
JoMay Chow. (2002) Probiotics and prebiotics: A brief overview. Journal of Renal Nutrition 12:2, pages 76-86.
Crossref
Crossref
David M Aronoff. (2001) Using Live Pathogens to Treat Infectious Diseases: A Historical Perspective on the Relationship between Gb Virus C and HIV. Antiviral Therapy 7:2, pages 73-80.
Crossref
Crossref
John G. Bartlett. (2002) Antibiotic-Associated Diarrhea. New England Journal of Medicine 346:5, pages 334-339.
Crossref
Crossref
Scott D. Lee & Christina M. Surawicz. (2001) INFECTIOUS CAUSES OF CHRONIC DIARRHEA. Gastroenterology Clinics of North America 30:3, pages 679-692.
Crossref
Crossref
William P. CieslaJrJr & David A. Bobak. (2001) Management and prevention of Clostridium difficile-associated diarrhea. Current Infectious Disease Reports 3:2, pages 109-115.
Crossref
Crossref
M. H. Wilcox & J. Dave. (2001) Treatment options in Clostridium difficile infection. Reviews in Medical Microbiology 12:1, pages 21-28.
Crossref
Crossref
Omar J. Pérez Jiménez. 2001. Critical Care Infectious Diseases Textbook. Critical Care Infectious Diseases Textbook
721
729
.
Seth E. Persky & Lawrence J. Brandt. (2000) Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. The American Journal of Gastroenterology 95:11, pages 3283-3285.
Crossref
Crossref
Subhas Banerjee & J. Thomas Lamont. (2000) Non-antibiotic therapy for Clostridium difficile infection. Current Opinion in Infectious Diseases 13:3, pages 215-219.
Crossref
Crossref
Rial D. Rolfe. (2000) The Role of Probiotic Cultures in the Control of Gastrointestinal Health. The Journal of Nutrition 130:2, pages 396S-402S.
Crossref
Crossref
Glenn R. Gibson & Roy Fuller. (2000) Aspects of In Vitro and In Vivo Research Approaches Directed Toward Identifying Probiotics and Prebiotics for Human Use. The Journal of Nutrition 130:2, pages 391S-395S.
Crossref
Crossref
R.C. Chandan. (1999) Enhancing Market Value of Milk by Adding Cultures. Journal of Dairy Science 82:10, pages 2245-2256.
Crossref
Crossref
S. P. Borriello & C. Roffe. 1999. Medical Importance of the Normal Microflora. Medical Importance of the Normal Microflora
371
387
.
Per G. Falk, Lora V. Hooper, Tore Midtvedt & Jeffrey I. Gordon. (1998) Creating and Maintaining the Gastrointestinal Ecosystem: What We Know and Need To Know from Gnotobiology. Microbiology and Molecular Biology Reviews 62:4, pages 1157-1170.
Crossref
Crossref
Robert K. Cleary. (1998) Clostridium difficile-associated diarrhea and colitis. Diseases of the Colon & Rectum 41:11, pages 1435-1449.
Crossref
Crossref
John A. Kink & Jim A. Williams. (1998)
Antibodies to Recombinant
Clostridium difficile
Toxins A and B Are an Effective Treatment and Prevent Relapse of
C. difficile
-Associated Disease in a Hamster Model of Infection
. Infection and Immunity 66:5, pages 2018-2025.
Crossref
Crossref
John M Starr, Tom R Rogers & Mario Impallomeni. (1997) Hospital-acquired Clostridium difficile diarrhoea and herd immunity. The Lancet 349:9049, pages 426-428.
Crossref
Crossref
J.M. Starr & M Impallomeni. (1997) Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly. Biomedicine & Pharmacotherapy 51:2, pages 63-67.
Crossref
Crossref
G. R. Gibson, J. M. Saavedra, S. Macfarlane & G. T. Macfarlane. 1997. Probiotics 2. Probiotics 2
10
39
.
Rial D. Rolfe. 1997. Gastrointestinal Microbiology. Gastrointestinal Microbiology
501
536
.
Haru Kato, Naoki Kato, Kunitomo Watanabe, Kazue Ueno, Yoko Sakata & Kozo Fujita. (1996) Relapses or reinfections: Analysis of a case of Clostridium difficile-associated colitis by two typing systems. Current Microbiology 33:4, pages 220-223.
Crossref
Crossref
Dr Roy Fuller. (2007) VIEWPOINT. Nutrition Bulletin 21:3, pages 204-208.
Crossref
Crossref
Christine Roffe. (1996) Biotherapy for antibiotic-associated and other diarrhoeas. Journal of Infection 32:1, pages 1-10.
Crossref
Crossref
Jan Winberg, Maria Herthelius-Elman, Roland M�llby & Carl Erik Nord. (1993) Pathogenesis of urinary tract infection ?experimental studies of vaginal resistance to colonization. Pediatric Nephrology 7:5, pages 509-514.
Crossref
Crossref
Val H. Smith. (1993) Resource Competition between Host and Pathogen. BioScience 43:1, pages 21-30.
Crossref
Crossref
Val H. Smith. 1993. Advances in Microbial Ecology. Advances in Microbial Ecology
1
37
.
M.H. Wilcox & R.C. Spencer. (1992) Clostridium difficile infection: responses, relapses and re-infections. Journal of Hospital Infection 22:2, pages 85-92.
Crossref
Crossref
H E LarsonS P Borriello. (1990) Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters. Antimicrobial Agents and Chemotherapy 34:7, pages 1348-1353.
Crossref
Crossref
Michael B. Kimmey, Gary W. Elmer, Christina M. Surawicz & Lynne V. McFarland. (1990) Prevention of further recurrences ofClostridium difficile colitis withSaccharomyces boulardii. Digestive Diseases and Sciences 35:7, pages 897-901.
Crossref
Crossref
M HertheliusS L GorbachR MöllbyC E NordL PetterssonJ Winberg. (1989) Elimination of vaginal colonization with Escherichia coli by administration of indigenous flora. Infection and Immunity 57:8, pages 2447-2451.
Crossref
Crossref
R. FULLER AFRC. (1989) Probiotics in man and animals. Journal of Applied Bacteriology 66:5, pages 365-378.
Crossref
Crossref
M. Tvede & J. Rask-Madsen. (1989) BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS. The Lancet 333:8648, pages 1156-1160.
Crossref
Crossref
Robert Ducluzeau, Marc Cerf, Gérard Corthier, Jean-Claude Rambaud, Paul Chapoy, Yannick Aujard & Gary W. ElmerJ. C. Rambaud, Ph. Marteau, I. Sobhani & O. Berretta. 1989. Microbial Ecology and Intestinal Infections. Microbial Ecology and Intestinal Infections
57
72
.
S. P. Borriello. 1989. The Regulatory and Protective Role of the Normal Microflora. The Regulatory and Protective Role of the Normal Microflora
239
251
.
D M LyerlyH C KrivanT D Wilkins. (1988) Clostridium difficile: its disease and toxins. Clinical Microbiology Reviews 1:1, pages 1-18.
Crossref
Crossref
KENNETH H. WILSON. 1988. Clostridium Difficile. Clostridium Difficile
183
200
.
D. Seal, S. P. Borriello, F. Barclay, A. Welch, M. Piper & M. Bonnycastle. (1987) Treatment of relapsingClostridium difficile diarrhoea by administration of a non-toxigenic strain. European Journal of Clinical Microbiology 6:1, pages 51-53.
Crossref
Crossref